Hospitalization due to serious SAEs in 158 AML patients
| Parameter . | Value . |
|---|---|
| Hospitalization,* no. (%) | 99 (63) |
| Hospitalization due to drug-related AE, no. (%) | 59 (37) |
| Mean duration of hospitalization due to drug-related AE, d (SD) | 17 (12.7) |
| Median duration of hospitalization due to drug-related AE, d (range) | 14 (2-58) |
| Parameter . | Value . |
|---|---|
| Hospitalization,* no. (%) | 99 (63) |
| Hospitalization due to drug-related AE, no. (%) | 59 (37) |
| Mean duration of hospitalization due to drug-related AE, d (SD) | 17 (12.7) |
| Median duration of hospitalization due to drug-related AE, d (range) | 14 (2-58) |
Some patients had more than one reason for hospitalization. Duration of hospitalization was calculated for patients who had at least one hospitalization due to SAE related to drug treatment.
SAE indicates serious adverse event.
Some patients were hospitalized for observation only at the beginning of the study for safety reasons and not due to SAEs.